BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6138817)

  • 1. Ranitidine and other H2-receptor antagonists: recent developments.
    Daly MJ; Price BJ
    Prog Med Chem; 1983; 20():337-68. PubMed ID: 6138817
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
    Palacios B; Montero MJ; Sevilla MA; San Román L
    Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H2-antagonists--past, present and future.
    Brittain RT; Jack D
    J Clin Gastroenterol; 1983; 5 Suppl 1():71-9. PubMed ID: 6140285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effects of a new histamine H2 receptor agonist (impromidine) and antagonist (ranitidine).
    Pollock DM; Banks RO; Jacobson ED
    Pharmacol Res Commun; 1982 Jul; 14(7):605-12. PubMed ID: 6127724
    [No Abstract]   [Full Text] [Related]  

  • 7. Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay.
    Black JW; Leff P; Shankley NP
    Br J Pharmacol; 1985 Nov; 86(3):581-7. PubMed ID: 2866002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric acid response to topical or intravenous histamine and topical H2-receptor blockade in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Harrison C
    Agents Actions; 1981 Nov; 11(5):437-41. PubMed ID: 6121473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems.
    Orsetti M
    Agents Actions; 1988 Dec; 25(3-4):291-5. PubMed ID: 2905866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
    Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
    Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of H2-receptor antagonists cimetidine, ranitidine, and ICI 125,211 on histamine-stimulated adenylate cyclase activity in guinea pig gastric mucosa.
    Cheret AM; Pignal F; Lewin MJ
    Mol Pharmacol; 1981 Sep; 20(2):326-30. PubMed ID: 6117786
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
    Pagani F; Zecca M; Giachetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):349-51. PubMed ID: 2891046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
    Palacios B; Montero MJ; Sevilla MA; Román LS
    Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and gastric acid antisecretory properties of the H2-receptor antagonist. N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]thieno[3,4-d]isot hiazol-3-amine 1,1-dioxide and related derivatives.
    Santilli AA; Scotese AC; Morris RL; Schiehser GA; Teller DM; Nielsen ST; Strike DP
    J Med Chem; 1988 Jul; 31(7):1480-6. PubMed ID: 2898534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
    Batzri S; Harmon JW; Dyer J; Thompson WF
    Mol Pharmacol; 1982 Jul; 22(1):41-7. PubMed ID: 6126804
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
    Krielaart MJ; Veenstra DM; van Buuren KJ
    Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.